Vectura Group plc

Company Information

Address:

1 Prospect West
Chippenham
Wiltshire
SN14 6FH

Tel:

+44 (0)1249 667700

Fax:

+44 (0)1249 667701

E-Mail:

Secretary:

Anne Hyland

Registrar:

Company Overview

Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura’s main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25 billion.

Annual Reports

Description Report Date Published
Annual Report 201231-03-201225-04-2012
Annual Report 201131-03-201122-05-2011
Annual Report 201031-03-201006-06-2010
Annual Report 200931-03-200918-05-2009
Annual Report 200831-03-200821-05-2008
Annual Report 200731-03-200722-05-2007
Annual Report 200631-03-200624-05-2006
Annual Report 200531-03-200524-06-2005

Interim Reports

Description Report Date Published
Interim Report 201230-09-201219-11-2012
Interim Report 201130-09-201113-11-2011
Interim Report 201030-09-201015-11-2010
Interim Report 200930-09-200926-11-2009
Interim Report 200830-09-200823-11-2008
Interim Report 200730-09-200726-11-2007
Interim Report 200630-09-200617-11-2006
Interim Report 200530-09-200516-11-2005

Dividend Histroy

Type Dividend Payment Date
A B C D E F G
H I J K L M
N O P Q R S T
U V W X Y Z #